The Role of DPP-4 Inhibitors in Type-2 Diabetes Patients with Chronic Kidney Disease-Reference-Cited by-同舟云学术

The Role of DPP-4 Inhibitors in Type-2 Diabetes Patients with Chronic Kidney Disease

Published:2021 Issue:3 Volume:12 Page:91-94
ISSN:2229-5402
Container-title:Pharmacophore
language:
Short-container-title:Pharmacophore

Author:

Alqurashi Mishal Yousef,Alharthi Khalid Faisal,Alshehri Abdulaziz Abdulrahman,Alharbi Yazeed Khalid,Sanousi Mohammad Abdulmunem,Almazyed Anas Abdullah,Alghamdi Khulud Saeed,Alrashidi Sarah Musaad,Qaeed Waad Abdullah,Alasmari Amjad Aedh

Publisher

Polaris

Subject

General Medicine,General Chemistry

Reference20 articles.

1. 1. Ogurtsova K, Da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40-50. doi:10.1016/j.diabres.2017.03.024

2. 2. Glovaci D, Fan W, Wong ND. Epidemiology of Diabetes Mellitus and Cardiovascular Disease. Curr Cardiol Rep. 2019;21(4):21. doi:10.1007/s11886-019-1107-y

3. 3. Luo Y, Lu K, Liu G, Wang J, Laurent I, Zhou X. The Effects of Novel Antidiabetic Drugs on Albuminuria in Type 2 Diabetes Mellitus: A Systematic Review and Meta-analysis of Randomized Controlled Trials. Clin Drug Investig. 2018;38(12):1089-108.

4. 4. Dal Canto E, Ceriello A, Rydén L, Ferrini M, Hansen TB, Schnell O, et al. Diabetes as a cardiovascular risk factor: An overview of global trends of macro and microvascular complications. Eur J Prev Cardiol. 2019;26(2_suppl):25-32. doi:10.1177/2047487319878371

5. 5. Fei Y, Tsoi MF, Kumana CR, Cheung TT, Cheung BMY. Network meta-analysis of cardiovascular outcomes in randomized controlled trials of new antidiabetic drugs. Int J Cardiol. 2018;254:291-6. doi:10.1016/j.ijcard.2017.12.039

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Review of the Level of Depression in Patients with Diabetes;Archives of Pharmacy Practice;2023

2. Evaluation of Drug Prescribing Trends and Drug-Drug Interactions among Chronic Kidney Disease Patients;Journal of Biochemical Technology;2022